학술논문
Foretinib, a c-MET receptor tyrosine kinase inhibitor, tackles multidrug resistance in cancer cells by inhibiting ABCB1 and ABCG2 transporters
Document Type
Article
Author
Source
In Toxicology and Applied Pharmacology March 2024 484
Subject
Language
ISSN
0041-008X